The phrase "absolute years" is correct and usable in written English.
It can be used in contexts discussing time measurement, particularly in fields like geology, archaeology, or astronomy, where specific time frames are referenced.
Example: "The fossils were dated to absolute years, providing a clearer timeline of the species' existence."
Alternatives: "fixed years" or "definite years".
On the second interpretation (i.e., the absolute one), the demands of egalitarianism are essentially non-comparative: a 'priority of health' principle requires that a given person have as much health as possible, as judged by some non-comparative metric (e.g., absolute years of life expectancy).
In addition, education may be an even stronger effect modifier when absolute years of education can be incorporated.
Notable exceptions to this were the Indian, Pakistani and Black African groups where women's absolute years of DFLE were the same or less than those of men.
PAFs were applied to the relevant conditions to estimate absolute years lost and the percentage of the 2009 illness duration total.
τ values were not converted to absolute years because of uncertainty associated with estimating mutation rates in fishes [ 103] and because comparisons were relative among regions and reefs.
Except in 1951 80 for both sex groups and 1921 40 for males and 1971 90 for females, the annual contribution of absolute years to life expectancy was below the overall average showing a low pace in those decades.
In particular, the U.S. and South Korea saw the greatest growth in market share of worldwide Google Play consumer spend, but the U.S. and Japan saw the largest absolute growth year-over-year.
In this analysis, absolute time (years) was used to approximate the number of generations.
Four years, absolute, absolute maximum.
The highest absolute 10 year risk of rheumatoid arthritis of 32% was observed in 50-69 years old women who smoked with rheumatoid factor levels >100 IU/mL.
The results confirm the advantage in overall survival in favor of the chemoradiotherapy with an absolute 5-year overall survival benefit of 6% (60 66%) and 8% of 5-year disease-free survival (50 58%).
